Abiopharma

🔍 SMITH PATRICK W (Director)

Company: AXON ENTERPRISE, INC. (AXON)

Report Date: 2026-08-16

Detailed Transactions and Holdings:

• Acquired 97,015 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,128,012.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The transaction consists of performance-based restricted stock units granted on December 22, 2023, for the achievement of the fourth tranche of the 2024 CEO Performance Award, for which the performance conditions were determined to have been certified by the Compensation Committee on August 16, 2026. The units will vest on December 31, 2029, subject to continued employment through such date. Following the vesting of each tranche, the shares applicable to each tranche are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld to cover taxes.